News Detail

Biomerica signs CDMO services deal for over $1.75 million in IVD assay development fees

PUBT · 05/28 12:19

Listen to the news

Biomerica signs CDMO services deal for over $1.75 million in IVD assay development fees

Biomerica signed a Master Services Agreement with a confidential life sciences company to develop proprietary IVD assays.
Initial contract development target fee exceeds USD 1.75 million, earned across multiple statements of work under the agreement.
Three-year term with automatic one-year renewals; revenue recognized on milestone completion as deliverables are accepted.
Work to be performed at its FDA-licensed, ISO 13485-certified Irvine facility using existing staff and equipment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biomerica Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605280819PRIMZONEFULLFEED9727956) on May 28, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.